C12H10N2OS
230.29 g/mol
APIWarning
2-methyl-5,10-dihydro-4h-thieno[2,3-b][1,5]benzodiazepin-4-one
CAS221176-49-4EC629-926-9
Category
API
Compound Class
Heterocycle
Primary Use
Pharmaceutical Raw Material
This compound is an active pharmaceutical ingredient impurity associated with the production of certain drugs. Its structure contains an amide and an amine group within a fused ring system, indicating it is a small-molecule impurity relevant to pharmaceutical manufacturing.
Reference standard for impurity analysis in pharmaceutical manufacturingUsed in quality control testing of active pharmaceutical ingredients
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 221176-49-4
Related Compounds
ReferenceSame Category
4-Amino-5-chloro-2-methoxy-N-(3-methoxypiperidin-4-yl)benzene-1-carboximidic acid--hydrogen chloride (1/1)
CAS221180-26-3
pharmaceutical raw material
ReferenceSame Category
Orforglipron
CAS2212020-52-3
pharmaceutical raw material
ReferenceSame Category
AOD 9604
CAS221231-10-3
pharmaceutical raw material
ReferenceSame Category
Olanzapine pamoate hydrate
CAS221373-18-8
pharmaceutical raw material
Safety Reference
Warning
H335May cause respiratory irritation
Identifiers
IUPAC Name
2-methyl-5,10-dihydrothieno[3,2-c][1,5]benzodiazepin-4-one
InChIKey
LVTDAJJOMLNXFS-UHFFFAOYSA-N
SMILES
CC1=CC2=C(S1)NC3=CC=CC=C3NC2=O
Synonyms (18)
- OLANZAPINE IMPURITY B (EP IMPURITY)
- Olanzapine EP Impurity B; Olanzapine USP Rc B
- OLANZAPINE IMPURITY B
- Olanzapine-lactam
- Olanzapine-related Compound B